Blog

Our Annual Cancer Immunotherapy Update – Life Science Leader Magazine

Our Annual Cancer Immunotherapy Update
Life Science Leader Magazine
When we started our series, “Combination Cancer Immunotherapy — A Virtual Roundtable,” in 2014, our basic assumptions were not the consensus view. We assumed immunotherapy, now more commonly called immuno-oncology (IO), would become the …

2017-06-07 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.